These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23656572)

  • 1. 'Be Clear on Cancer': the impact of the UK National Bowel Cancer Awareness Campaign.
    Peacock O; Clayton S; Atkinson F; Tierney GM; Lund JN
    Colorectal Dis; 2013 Aug; 15(8):963-7. PubMed ID: 23656572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bowel cancer awareness campaign 'Be Clear on Cancer': sustained increased pressure on resources and over-accessed by higher social grades with no increase in cancer detected.
    Hall SJ; Peacock JD; Cochrane LA; Peacock O; Tierney GM; Tou SI; Lund JN
    Colorectal Dis; 2016 Feb; 18(2):195-9. PubMed ID: 26333198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the United kingdom national bowel cancer awareness campaign on colorectal services.
    Pande R; Leung E; McCullough P; Smith S; Harmston C
    Dis Colon Rectum; 2014 Jan; 57(1):70-5. PubMed ID: 24316948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the United Kingdom national bowel cancer awareness campaigns 2012 on colorectal cancer services and patient survival.
    Khong TL; Naik K; Sivakumar R; Shah S
    Colorectal Dis; 2015 Dec; 17(12):1055-61. PubMed ID: 26096269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Did the 'Be Clear on Bowel Cancer' public awareness campaign pilot result in a higher rate of cancer detection?
    Bethune R; Marshall MJ; Mitchell SJ; Oppong C; Cartmel MT; Arumugam PJ; Gee AS; Daniels IR
    Postgrad Med J; 2013 Jul; 89(1053):390-3. PubMed ID: 23572594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the United kingdom national bowel cancer awareness campaign on colorectal services.
    Bhalla A; Peacock O; Lund JN
    Dis Colon Rectum; 2015 Jun; 58(6):e393-4. PubMed ID: 25944440
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary-to-secondary care referral experience of suspected colorectal malignancy in young adults.
    Patel K; Doulias T; Hoad T; Lee C; Alberts JC
    Ann R Coll Surg Engl; 2016 May; 98(5):308-13. PubMed ID: 27023637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-week wait symptoms are prevalent in screened patients with a positive faecal occult blood test but do not predict cancer.
    Vaughan-Shaw PG; Cutting J; Borley N; Brooklyn T; Wheeler JM
    Colorectal Dis; 2014 Jan; 16(1):40-7. PubMed ID: 24103034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2-week wait service: a UK tertiary colorectal centre's experience in the early identification of colorectal cancer.
    Patel RK; Sayers AE; Seedat S; Altayeb T; Hunter IA
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1408-14. PubMed ID: 25244412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia.
    Worthington J; Feletto E; Lew JB; Broun K; Durkin S; Wakefield M; Grogan P; Harper T; Canfell K
    Public Health; 2020 Feb; 179():90-99. PubMed ID: 31760206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care referral practice, variability and socio-economic deprivation in colorectal cancer.
    Borowski DW; Cawkwell S; Zaidi SM; Toward M; Maguire N; Gill TS
    Colorectal Dis; 2016 Nov; 18(11):1072-1079. PubMed ID: 27110954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The straight to test endoscopy service for suspected colorectal cancer: meeting national targets but are we meeting our patients' expectations?
    Hitchins CR; Lawn A; Whitehouse G; McFall MR
    Colorectal Dis; 2014 Aug; 16(8):616-9. PubMed ID: 24629037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a mass media campaign on participation rates in a National Bowel Cancer Screening Program: a field experiment.
    Durkin SJ; Broun K; Spittal MJ; Wakefield MA
    BMJ Open; 2019 Jan; 9(1):e024267. PubMed ID: 30813110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of "Be Clear on Cancer" campaign on breast care services provided by a specialist oncoplastic unit - A retrospective case control study.
    Mazari FAK; Holt S; Azmy IA
    Int J Surg; 2017 Nov; 47():54-60. PubMed ID: 28951287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The misuse of the faecal occult blood test under the lower gastrointestinal two week wait rule.
    Shaw AG; Lund JN; Longman C; Tierney GM; Goddard AF
    Colorectal Dis; 2009 Jan; 11(1):94-6. PubMed ID: 18462248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in urgent referrals for suspected colorectal cancer: an increase in quantity, but not in quality.
    Vulliamy P; McCluney S; Raouf S; Banerjee S
    Ann R Coll Surg Engl; 2016 Nov; 98(8):564-567. PubMed ID: 27551894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the bowel-screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran.
    Roxburgh CS; McTaggart F; Balsitis M; Diament RH
    Colorectal Dis; 2013 Jan; 15(1):34-41. PubMed ID: 22632378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2015 upper gastrointestinal "Be Clear on Cancer" campaign: its impact on gastroenterology services and malignant and premalignant diagnoses.
    Siau K; Yew AC; Hingley S; Rees J; Trudgill NJ; Veitch AM; Fisher NC
    Frontline Gastroenterol; 2017 Oct; 8(4):284-289. PubMed ID: 29067155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Referral proformas improve compliance to national colorectal 2-week wait targets: does this affect cancer detection rates?
    Jani A; Jenner L; Ma F; Dutton S; Stevens R; Sharma RA;
    Colorectal Dis; 2012 Nov; 14(11):1351-6. PubMed ID: 22360704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal cancer symptoms: Evaluation of the impact of a regional public awareness campaign.
    Torrance N; Bright CJ; Hill HL; Fergusson J; Kennedy C; Mak V; Gildea C; Nordin A; Elliss-Brookes L
    Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13500. PubMed ID: 34382254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.